Evaluation of skin expression profiles of patients with vitiligo treated with narrow-band UVB therapy by targeted RNA-seq
- PMID: 30484529
- PMCID: PMC6256230
- DOI: 10.1590/abd1806-4841.20187589
Evaluation of skin expression profiles of patients with vitiligo treated with narrow-band UVB therapy by targeted RNA-seq
Abstract
Background: Vitiligo is characterized by a lack of pigmentation in the skin. To date, there are no studies that analyze the changes in gene expression in the skin of vitiligo patients in response to narrow-band ultraviolet B (nb-UVB) phototherapy treatment.
Objective: Explore the usefulness of new generation RNA sequencing in the identification of gene expression changes in the skin of vitiligo patients treated with nb-UVB phototherapy.
Methods: Four skin biopsies (4mm in diameter) were collected from 45 Mexican vitiligo vulgaris patients, 2 specimens before and 2 after treatment with nb-UVB phototherapy, obtained from pigmented and non-pigmented tissue. RNA extracted from the biopsies was analyzed using the Illumina TruSeq Targeted RNA Expression protocol to study the expression of genes that participate in pathways of skin homeostasis. The 2 groups were compared using Student's t-test and the Mann-Whitney U-test.
Results: The expression analysis identified differences in 12 genes included in this study after comparing the samples obtained before and after treatment: 5 genes involved in skin pigmentation, 2 genes involved in apoptosis, 2 genes involved in cell survival, 2 genes involved in oxidative stress responses and 1 gene involved in signal transduction mechanisms (p<0.05).
Study limitations: The small size of skin biopsies limits the amount of RNA obtained, the number of genes to be analyzed and the use of conventional techniques such as RT-qPCR.
Conclusion: We demonstrated usefulness of new generation RNA sequencing in the identification of gene expression changes, in addition to identifying new targets in the study of vitiligo.
Conflict of interest statement
Conflict of interest: None.
Figures


Similar articles
-
Effect of narrow-band ultraviolet B on the serum of 25-hydroxyvitamin D in vitiligo patients.J Cosmet Dermatol. 2018 Oct;17(5):911-916. doi: 10.1111/jocd.12515. Epub 2018 Mar 10. J Cosmet Dermatol. 2018. PMID: 29524288
-
Tacalcitol and narrow-band phototherapy in patients with vitiligo.Clin Exp Dermatol. 2006 Mar;31(2):200-5. doi: 10.1111/j.1365-2230.2005.02037.x. Clin Exp Dermatol. 2006. PMID: 16487090 Clinical Trial.
-
Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.Photodermatol Photoimmunol Photomed. 2017 Jan;33(1):22-31. doi: 10.1111/phpp.12277. Epub 2016 Nov 23. Photodermatol Photoimmunol Photomed. 2017. PMID: 27696531 Review.
-
Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.Acta Derm Venereol. 2008;88(4):376-81. doi: 10.2340/00015555-0469. Acta Derm Venereol. 2008. PMID: 18709309 Clinical Trial.
-
Clinical efficacy and safety profile of handheld narrow band ultraviolet B device therapy in vitiligo - Systematic review and meta-analysis.Indian J Dermatol Venereol Leprol. 2025 May-Jun;91(3):321-331. doi: 10.25259/IJDVL_71_2024. Indian J Dermatol Venereol Leprol. 2025. PMID: 39912150
Cited by
-
Transcriptome Analysis and Emerging Driver Identification of CD8+ T Cells in Patients with Vitiligo.Oxid Med Cell Longev. 2019 Nov 26;2019:2503924. doi: 10.1155/2019/2503924. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31885781 Free PMC article.
-
What Is New in Narrow-Band Ultraviolet-B Therapy for Vitiligo?Indian Dermatol Online J. 2019 May-Jun;10(3):234-243. doi: 10.4103/idoj.IDOJ_310_18. Indian Dermatol Online J. 2019. PMID: 31149564 Free PMC article. Review.
-
Differentially Expressed Circular RNAs and Their Therapeutic Mechanism in Non-segmental Vitiligo Patients Treated With Methylprednisolone.Front Med (Lausanne). 2022 May 16;9:839066. doi: 10.3389/fmed.2022.839066. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35652072 Free PMC article.
-
Cullin-3 and Regulatory Biomolecules Profiling in Vitiligo: Integrated Docking, Clinical, and In Silico Insights.Biomolecules. 2025 Jul 21;15(7):1053. doi: 10.3390/biom15071053. Biomolecules. 2025. PMID: 40723924 Free PMC article.
-
Pooled Sequencing Analysis of Geese (Anser cygnoides) Reveals Genomic Variations Associated With Feather Color.Front Genet. 2021 Jun 18;12:650013. doi: 10.3389/fgene.2021.650013. eCollection 2021. Front Genet. 2021. PMID: 34220935 Free PMC article.
References
-
- Sehgal VN, Srivastava G. Vitiligo: compendium of clinico-epidemiological features. Indian J Dermatol Venereol Leprol. 2007;73:149–156. - PubMed
-
- Steiner D, Bedin V, Brito MB, Tadeu RT, Steiner T. Vitiligo. An Bras Dermatol. 2004;79:335–351.
-
- Spritz RA. The genetics of generalized vitiligo and associated autoimmune diseases. J Dermatol Sci. 2006;41:3–10. - PubMed
-
- Spritz RA. The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res. 2007;20:271–278. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical